Susquehanna International Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.21B Buy
3,487,400
+87,800
+3% +$89M 0.36% 43
2025
Q4
$3.65B Sell
3,399,600
-440,300
-11% -$421M 0.42% 43
2025
Q3
$2.93B Buy
3,839,900
+723,200
+23% +$538M 0.33% 49
2025
Q2
$2.43B Buy
3,116,700
+573,400
+23% +$446M 0.34% 46
2025
Q1
$2.1B Buy
2,543,300
+67,800
+3% +$56.4M 0.36% 42
2024
Q4
$1.91B Buy
2,475,500
+168,000
+7% +$139M 0.29% 50
2024
Q3
$2.04B Buy
2,307,500
+347,900
+18% +$313M 0.36% 39
2024
Q2
$1.77B Buy
1,959,600
+228,700
+13% +$183M 0.33% 45
2024
Q1
$1.35B Sell
1,730,900
-211,600
-11% -$151M 0.23% 67
2023
Q4
$1.13B Buy
1,942,500
+268,900
+16% +$157M 0.22% 62
2023
Q3
$899M Sell
1,673,600
-163,400
-9% -$84.2M 0.19% 68
2023
Q2
$862M Sell
1,837,000
-412,500
-18% -$173M 0.18% 66
2023
Q1
$773M Buy
2,249,500
+300,200
+15% +$101M 0.16% 80
2022
Q4
$713M Buy
1,949,300
+155,000
+9% +$55M 0.18% 82
2022
Q3
$580M Buy
1,794,300
+498,700
+38% +$158M 0.15% 90
2022
Q2
$420M Buy
1,295,600
+134,600
+12% +$40.4M 0.1% 141
2022
Q1
$332M Sell
1,161,000
-602,500
-34% -$155M 0.06% 252
2021
Q4
$487M Sell
1,763,500
-122,600
-7% -$31.1M 0.07% 211
2021
Q3
$436M Buy
1,886,100
+264,900
+16% +$65.4M 0.06% 277
2021
Q2
$372M Buy
1,621,200
+317,000
+24% +$63.7M 0.05% 298
2021
Q1
$244M Buy
1,304,200
+469,700
+56% +$91.9M 0.04% 384
2020
Q4
$141M Sell
834,500
-328,300
-28% -$49M 0.02% 532
2020
Q3
$172M Sell
1,162,800
-143,300
-11% -$22.2M 0.03% 383
2020
Q2
$214M Buy
1,306,100
+486,900
+59% +$74.7M 0.05% 284
2020
Q1
$114M Sell
819,200
-104,700
-11% -$14.4M 0.04% 350
2019
Q4
$121M Buy
923,900
+76,400
+9% +$8.86M 0.04% 415
2019
Q3
$94.8M Sell
847,500
-344,500
-29% -$38.4M 0.03% 456
2019
Q2
$132M Sell
1,192,000
-700
-0.1% -$82.4K 0.05% 328
2019
Q1
$155M Buy
1,192,700
+218,800
+22% +$26.6M 0.06% 260
2018
Q4
$113M Sell
973,900
-358,400
-27% -$40M 0.04% 344
2018
Q3
$143M Buy
1,332,300
+751,900
+130% +$75.2M 0.05% 336
2018
Q2
$49.5M Sell
580,400
-378,000
-39% -$31M 0.02% 685
2018
Q1
$74.2M Buy
958,400
+133,800
+16% +$10.8M 0.03% 497
2017
Q4
$69.6M Sell
824,600
-28,000
-3% -$2.38M 0.02% 554
2017
Q3
$72.9M Sell
852,600
-741,200
-47% -$60.8M 0.03% 497
2017
Q2
$131M Buy
1,593,800
+210,000
+15% +$17.1M 0.06% 276
2017
Q1
$116M Sell
1,383,800
-1,329,700
-49% -$107M 0.06% 287
2016
Q4
$200M Buy
2,713,500
+447,500
+20% +$33.3M 0.1% 173
2016
Q3
$182M Buy
2,266,000
+366,900
+19% +$29.4M 0.09% 186
2016
Q2
$150M Buy
1,899,100
+8,700
+0.5% +$655K 0.08% 207
2016
Q1
$136M Buy
1,890,400
+41,900
+2% +$3.17M 0.07% 228
2015
Q4
$156M Sell
1,848,500
-1,795,100
-49% -$149M 0.07% 234
2015
Q3
$305M Buy
3,643,600
+1,759,500
+93% +$149M 0.13% 126
2015
Q2
$157M Buy
1,884,100
+631,300
+50% +$48.1M 0.07% 261
2015
Q1
$91M Buy
1,252,800
+23,600
+2% +$1.68M 0.04% 398
2014
Q4
$84.8M Buy
1,229,200
+182,600
+17% +$12.3M 0.03% 471
2014
Q3
$67.9M Sell
1,046,600
-195,500
-16% -$12.4M 0.03% 577
2014
Q2
$77.2M Sell
1,242,100
-498,600
-29% -$29.7M 0.03% 480
2014
Q1
$102M Buy
1,740,700
+137,700
+9% +$7.68M 0.05% 343
2013
Q4
$81.8M Sell
1,603,000
-48,900
-3% -$2.45M 0.04% 424
2013
Q3
$83.1M Sell
1,651,900
-106,300
-6% -$5.57M 0.04% 370
2013
Q2
$86.4M Buy
+1,758,200
New +$95.7M 0.05% 312

Other funds holding LLY

Susquehanna International Group's LLY Position: Q1 2026 in Review

Susquehanna International Group reduced its Eli Lilly (LLY) stake by 35% in Q1 2026, selling an estimated $42.1M and leaving 78,552 shares worth $72.2M. The position accounts for 0.01% of the portfolio, ranked #1025.

Susquehanna International Group first reported a position in LLY in Q2 2013 and has held it in 48 quarters since. The position peaked at $383M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Susquehanna International Group held 78,552 shares of Eli Lilly worth $72.2M as of Q1 2026.
  • Susquehanna International Group sold 41,523 Eli Lilly shares in Q1 2026, an estimated $42.1M.
  • Eli Lilly made up 0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1025 holding.
  • Susquehanna International Group first reported a position in Eli Lilly in Q2 2013 and has held it in 48 quarters since.
  • Susquehanna International Group's Eli Lilly position peaked at $383M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.